Pasithea Therapeutics Corp. (KTTA) vs Palatin Technologies, Inc. (PTN)
Pasithea Therapeutics Corp. and Palatin Technologies, Inc. are both Biotechnology companies. Pasithea Therapeutics Corp. and Palatin Technologies, Inc. are of similar size ($17.5M and $17.2M). Pasithea Therapeutics Corp. has negative trailing earnings, so its P/E is not meaningful; Palatin Technologies, Inc. trades at 2.4×. Pasithea Therapeutics Corp. has the higher net margin (0.00% vs −47.2%) and the higher return on invested capital (−367.5% vs −942.3%). Across the 15 metrics below, Pasithea Therapeutics Corp. leads on 10 and Palatin Technologies, Inc. on 5.
Valuation
Profitability
| Metric | KTTA | PTN | Biotechnology median |
|---|---|---|---|
| Gross margin | 0.00% | 100.00% | 65.16% |
| Operating margin | 0.00% | (49.26%) | 0.00% |
| Net margin | 0.00% | (47.22%) | 0.00% |
| Free cash flow margin | 0.00% | (113.25%) | 0.00% |
| Return on equity | (65.49%) | (297.25%) | (57.72%) |
| Return on assets | (61.97%) | (73.72%) | (49.22%) |
| Return on invested capital | (367.46%) | (942.30%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack